Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Aug 13;13(8):e17152.
doi: 10.7759/cureus.17152. eCollection 2021 Aug.

Lung Transplantation in a Patient With COVID-19-Associated Acute Respiratory Failure

Affiliations
Case Reports

Lung Transplantation in a Patient With COVID-19-Associated Acute Respiratory Failure

Fatima Sajid et al. Cureus. .

Abstract

Coronavirus disease 2019 (COVID-19) is currently a significant cause of acute respiratory failure worldwide, leading to irreversible fibrotic lung disease. In patients with persistent respiratory failure after acute COVID-19 infection, lung transplant is an emerging option. Here, we have presented a case where the patient required venovenous extracorporeal membrane oxygenation (VV-ECMO) support for 33 days until a bilateral lung transplant was performed on day 71 after the initial COVID-19 infection. The early outcomes have been favorable. Currently, no guidelines exist for an acceptable time period after initial COVID-19 infection, duration of negative COVID polymerase chain reaction (PCR) testing, or negative Vero cell culture in the setting of persistent positive COVID PCR testing before listing for a lung transplant. Due to a lack of standardized guidelines, this patient was not listed for a lung transplant until the COVID-19 PCRs came negative on days 47 and 49 after the infection.

Keywords: acute lung injury; covid-19; lung fibrosis; lung transplant; respiratory failure.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. CT scan of the chest without contrast
CT scan of the chest without contrast (axial image) shows extensive pneumomediastinum and small right pneumothorax. Pneumatocele (yellow arrow), mild bronchiectasis, ground-glass opacities, and consolidations in bilateral lower lobes can be seen.
Figure 2
Figure 2. CT scan of the chest with contrast (coronal image) shows bronchiectasis involving predominantly lower lobes, reticular interstitial opacities, pneumatocele (yellow arrow), and upper lobe airspace opacities
Figure 3
Figure 3. CT scan of the chest with contrast (axial image) shows traction bronchiectasis (yellow arrow) and subpleural reticulations (red arrowhead) in the right lung base that is suggestive of progressive fibrosis
Figure 4
Figure 4. Timeline of clinical events
BiPAP: bilevel positive airway pressure, CRRT: continuous renal replacement therapy, DVT: deep vein thrombosis, ECMO: extracorporeal membrane oxygenation, IVC: inferior vena cava, PCR: polymerase chain reaction, SARS: severe acute respiratory syndrome.

References

    1. Lung transplantation for severe post-coronavirus disease 2019 respiratory failure. Hawkins RB, Mehaffey JH, Charles EJ, Mannem HC, Roeser M. Transplantation. 2021;105:1381–1387. - PubMed
    1. Lung transplantation for pulmonary fibrosis secondary to severe COVID-19 [PREPRINT] Bharat A, Querrey M, Markov NS, et al. medRxiv. 2020
    1. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Bharat A, Machuca TN, Querrey M, et al. Lancet Respir Med. 2021;9:487–497. - PMC - PubMed
    1. When to consider lung transplantation for COVID-19. Cypel M, Keshavjee S. Lancet Respir Med. 2020;8:944–946. - PMC - PubMed
    1. Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy. Doglietto F, Vezzoli M, Gheza F, et al. JAMA Surg. 2020;155:691–702. - PMC - PubMed

Publication types

LinkOut - more resources